Learn / BCRX
NASDAQ: BCRX
Biocryst Pharmaceuticals (BCRX) stock, explained like you're 5
Biocryst Pharmaceuticals trades on the Nasdaq under the ticker BCRX. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 2.2 billion dollars.
- Ticker
- BCRX
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Mid cap, about 2.2 billion dollars
Is Biocryst Pharmaceuticals a small, medium or large cap company?
No. Biocryst Pharmaceuticals is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 2.2 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Biocryst Pharmaceuticals makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves BCRX stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- BioCryst (BCRX) Trades at Just 11x Forward Earnings. Is the Market Pricing In Trouble? (Yahoo Finance)
- BioCryst Bets On Rare Genetic Disorder Therapy Expansion Amid Q2 Earnings Beat Retail Piles On Buyout Speculation (Stocktwits)
- How New Advisory Board At BioCryst Pharmaceuticals (BCRX) Has Changed Its Investment Story (Simply Wall Street)
- (BCRX) Volatility Zones as Tactical Triggers (Stock Traders Daily)
- Seven experts will advise BioCryst on rare disease drug research (Stock Titan)
Follow BCRX in your daily brief
Each trading day at 5 PM ET we post what happened to Biocryst Pharmaceuticals and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow BCRX
Questions about Biocryst Pharmaceuticals stock
What does Biocryst Pharmaceuticals do?
Biocryst Pharmaceuticals trades on the Nasdaq under the ticker BCRX. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 2.2 billion dollars.
What is the ticker symbol for Biocryst Pharmaceuticals?
Biocryst Pharmaceuticals trades under the ticker BCRX on the Nasdaq.
What is Biocryst Pharmaceuticals's market cap?
Biocryst Pharmaceuticals is a mid cap stock with a market cap of about 2.2 billion dollars.
How does Biocryst Pharmaceuticals make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves BCRX stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow BCRX stock every day?
Add BCRX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.